TC Biopharm () (TCBPW)
0.02
0.00 (0.50%)
At close: Jan 14, 2025, 10:46 AM
0.02
11.11%
Pre-market Jan 14, 2025, 10:47 AM EST
undefined% (undefined)
| Bid | 0.01 |
| Market Cap | 170.19K |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.754 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.02 |
| Volume | 6,376 |
| Avg. Volume (20D) | 0 |
| Open | 0.01 |
| Previous Close | 0.02 |
| Day's Range | 0.01 - 0.02 |
| 52-Week Range | 0.01 - 0.02 |
| Beta | undefined |
About TCBPW
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 41
Stock Exchange NASDAQ
Ticker Symbol TCBPW
Website https://www.tcbiopharm.com